The Primary Ciliary Dyskinesia Market driven by rising disease diagnosis rate

Primary ciliary dyskinesia is a rare genetic disorder characterized by defects in cilia structure and function. The cilia are microscopic hair-like structures present in various parts of the body including lungs, reproductive tract, and lining of the brain and spinal cord. PCD results in abnormal cilia that cannot effectively sweep away mucus and debris from the lungs and other areas. This leads to recurrent infections like chronic bronchitis, sinusitis, and ear infections from an early age. Diagnosis of PCD is challenging as its symptoms are often similar to those of other respiratory disorders like asthma and cystic fibrosis. Advances in genetic testing and high-speed video microscopy aided in improved identification of PCD in patients.

The primary ciliary dyskinesia market is estimated to be valued at USD 538.2 Mn in 2024 and is expected to reach USD 784.5 Mn by 2031, growing at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.

Primary Ciliary Dyskinesia Market -https://www.coherentmi.com/ind....ustry-reports/primar